Clinical Trial Update: A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 [Phase 1]

View source ↗

Summary

This update reports the completion of a first-in-human Phase 1 study evaluating HM12470 for safety, tolerability, pharmacokinetics, and pharmacodynamics in diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• HM12470

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED